Showing results (171-180 of 1,012) with videos related to

Sort By:
Pageof 102
Cancer Research Communications|August 30, 2023
Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing RegimensJosep Tabernero, Philippe L Bedard, Yung-Jue Bang, et al.
Cancer Research Communications|August 17, 2023
Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding ProteinsJunkai Wang, Alexander B Saltzman, Eric J Jaehnig, et al.
Cancer Research Communications|June 28, 2023
CD142 Identifies Neoplastic Desmoid Tumor Cells, Uncovering Interactions Between Neoplastic and Stromal Cells That Drive ProliferationMushriq Al-Jazrawe, Steven Xu, Raymond Poon, et al.
Cancer Research Communications|June 28, 2023
Dissecting the Origin of Heterogeneity in Uterine and Ovarian CarcinosarcomasAnne-Sophie Sertier, Anthony Ferrari, Roxane M Pommier, et al.
Cancer Research Communications|June 28, 2023
Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast CarcinomaPayal D Shah, Alexander C Huang, Xiaowei Xu, et al.
Cancer Research Communications|June 28, 2023
A Very Long-acting Exatecan and Its Synergism with DNA Damage Response InhibitorsShaun D Fontaine, Christopher W Carreras, Ralph R Reid, et al.
Cancer Research Communications|June 28, 2023
Antidepressant Use and Lung Cancer Risk and Survival: A Meta-analysis of Observational StudiesEunkyung Lee, Yongho Park, David Li, et al.
Cancer Research Communications|June 28, 2023
p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell DysfunctionDerek P Wong, Claire E Fritz, Daniel Feinberg, et al.
Cancer Research Communications|June 28, 2023
Targeting Fatty Acid Reprogramming Suppresses CARM1-expressing Ovarian CancerSimona Lombardi, Aaron R Goldman, Hsin-Yao Tang, et al.
Cancer Research Communications|June 28, 2023
A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal CancerEsteban Terzo, Shruti A Apte, Simran Padhye, et al.
Pageof 102